Laserfiche WebLink
DEFINITIONS <br /> A. Medical Waste: <br /> 1. Any biohazardous, pathology, pharmaceutical, or trace antineoplastic <br /> (chemotherapy) waste used in a health care setting. <br /> 2. Waste generated in testing of microbiological specimens. <br /> 3. Sharps and laboratory waste that poses a potential risk of infection to humans. <br /> 4. Waste generated in the cleanup of trauma scenes. <br /> B. Medical Waste Management Plan (MWMP): <br /> 1. A Medical Waste Management Plan has been developed to protect the public and <br /> the environment from potentially infectious disease causing agents. The MWMP <br /> regulates the generation, handling, storage,treatment, and disposal of medical <br /> waste. Any potential exposures to untreated medical, biohazardous, sharps or <br /> hazardous waste must be reported immediately. This applies to all Workforce <br /> members, providers and contractors including buildings owned, operated, and/or <br /> affiliated with SVMF. <br /> C. Sharps Waste: <br /> 1. Any device having acute rigid corners, edges, or protuberances capable of cutting or <br /> piercing. <br /> 2. Hypodermic needles, hypodermic needles with syringes, blades, needles with <br /> attached tubing, syringes contaminated with biohazardous waste and acupuncture <br /> needles. <br /> 3. Broken glass items, such as Pasteur pipettes and blood vials contaminated with <br /> biohazardous waste. <br /> 4. Any item capable of cutting or piercing that is contaminated with trauma scene <br /> waste. <br /> D. Biohazardous Waste: <br /> 1. Regulated medical waste, clinical waste, or biomedical waste that is a waste or <br /> reusable material derived from the medical treatment of a human, which includes <br /> diagnosis and immunization; or the testing of biological products. <br /> 2. Regulated medical waste or clinical waste or biomedical waste suspected of <br /> containing a highly communicable disease. <br /> 3. Laboratory waste such as human specimen cultures from the following activities: <br /> processing and performing tests on clinical specimens (including blood, urine, stool, <br /> nasopharyngeal & nasal specimens, vaginal swabs, and other bodily fluids), <br /> performing limited bacteria cultures, and performing gram stains identified by <br /> Section 173.134 of Title 49 of the Code of Federal Regulations as Category B. <br /> 4. Biohazardous wastes are wastes contaminated with visible or recognizable blood, <br /> blood products (e.g., plasma, platelets) and other potentially infectious bodily fluids. <br /> The term "biohazardous waste" is not limited to wastes "completely saturated or Ago& <br /> SVMF Waste Policy.Retrieved 8/23/2023.Official copy at http.//sh-sgmf.policystat.com/policy/13569979/.Copyright Page 2 of 14 <br /> 2023 Sutter Gould Medical Foundation <br />